Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease

Devan S Kowdley, Kris V Kowdley Liver Institute Northwest and Elson S. Floyd College of Medicine, Washington State University, Seattle, WA, USACorrespondence: Kris V KowdleyLiver Institute Northwest, 3216 NE 45th Place Suite 212, Seattle, WA, 98105, USATel +1 206-536-3030Fax +1 206-524-7429Email kko...

Full description

Bibliographic Details
Main Authors: Kowdley DS, Kowdley KV
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:The Application of Clinical Genetics
Subjects:
non-hfe
hemochromatosis
juvenile hemochromatosis
ferroportin disease
transferrin-receptor 2
hamp
hepcidin
Online Access:https://www.dovepress.com/appropriate-clinical-genetic-testing-of-hemochromatosis-type-24-includ-peer-reviewed-fulltext-article-TACG

Internet

https://www.dovepress.com/appropriate-clinical-genetic-testing-of-hemochromatosis-type-24-includ-peer-reviewed-fulltext-article-TACG

Similar Items